Drug:
Reaction: PRODUCT USE ISSUE
20250101 - 20251231
No. 401 - 500
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 401 | 25087314 |
CA |
50 | 2 |
Anti-cyclic citrullinated peptide antibody positive, Type 2 diabetes mellitus, C-reactive protein abnormal, Ill-defined disorder, Blood cholesterol increased, Rheumatoid arthritis, Dizziness, Lower limb fracture, Product use issue, Therapy non-responder, Musculoskeletal stiffness, Therapeutic product effect decreased, Duodenal ulcer perforation, Liver disorder, Glossodynia, Systemic lupus erythematosus, Nasopharyngitis, Swollen joint count, General physical health deterioration, Sleep disorder due to general medical condition, hypersomnia type, Autoimmune disorder, Bursitis, Abdominal discomfort, Joint range of motion decreased, Folliculitis, Gastrointestinal disorder, Irritable bowel syndrome, Arthralgia, Injury, Gait inability, Liver injury, Peripheral venous disease, Prescribed overdose, Fibromyalgia, Contraindicated product administered, Asthenia, Infection, Hepatic enzyme increased, Sciatica, Asthma, Peripheral swelling, Hypoaesthesia, Arthropathy, Dry mouth, Obesity, Psoriatic arthropathy, Contusion, Drug hypersensitivity, Dyspnoea, Confusional state, Blister, Wound, Rheumatoid factor positive, Maternal exposure during pregnancy, C-reactive protein, Mobility decreased, Musculoskeletal pain, Hypersensitivity, Paraesthesia, Lung disorder, Muscle spasms, Malaise, Helicobacter infection, Infusion related reaction, Sinusitis, Inflammation, Impaired healing, Anxiety, Hip arthroplasty, Pain, Lip dry, Pyrexia, Knee arthroplasty, Joint swelling, Vomiting, Sleep disorder due to general medical condition, insomnia type, Decreased appetite, Wheezing, Abdominal pain upper, Condition aggravated, Osteoarthritis, Tender joint count, Hand deformity, Pruritus, Fatigue, Weight increased, Facet joint syndrome, Pericarditis, Alopecia, Nausea, Discomfort, Stomatitis, Urticaria, Diarrhoea, Night sweats, Rash, Hypertension, Pemphigus, Lower respiratory tract infection, Oedema, Pregnancy, Rheumatic fever, Treatment failure, Drug ineffective, Swelling, Road traffic accident, Deep vein thrombosis postoperative, Synovitis, Chest pain, Muscle injury, Intentional product use issue, Headache, Swollen joint count increased, Drug intolerance, |
||||
METHOTREXATE, METHOTREXATE SODIUM, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, SECUKINUMAB, SECUKINUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, MELOXICAM, OXYCODONE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, MAGNESIUM, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, ERGOCALCIFEROL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, LANSOPRAZOLE, CALCIUM GLUCONATE, CALCIUM GLUCONATE, LANSOPRAZOLE, LORAZEPAM, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, METHYLPREDNISOLONE SODIUM SUCCINATE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PIROXICAM, DICLOFENAC SODIUM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, SULFASALAZINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, VITAMIN C, VITAMIN C, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, RAMIPRIL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, CALCIUM, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, HYALURONIDASE, CAFFEINE CITRATE, RISEDRONATE SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, CETRIMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, MOXIFLOXACIN HYDROCHLORIDE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE BUTYRATE, LISINOPRIL, LISINOPRIL, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, CAFFEINE, SARILUMAB, SARILUMAB, SARILUMAB, LORAZEPAM, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, LISINOPRIL, |
||||
| 402 | 25087452 |
US |
62 | 2 |
Osteoarthritis, Blood pressure abnormal, Weight increased, Product use issue, Off label use, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, |
||||
| 403 | 25087456 |
US |
1 | |
Product use issue, Product dispensing issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 404 | 25087502 |
US |
74 | 1 |
Pemphigoid, Product use issue, |
||||
PEMBROLIZUMAB, PACLITAXEL, CARBOPLATIN, |
||||
| 405 | 25087551 |
US |
2 | |
Hallucination, Cognitive disorder, Symptom recurrence, Delusion, Memory impairment, Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 406 | 25087644 |
US |
1 | |
Personality change, Feeling abnormal, Fall, Inability to afford medication, Product use issue, |
||||
PIMAVANSERIN TARTRATE, QUETIAPINE, |
||||
| 407 | 25087774 |
US |
||
Product use issue, Product contamination, |
||||
MEDROXYPROGESTERONE ACETATE, |
||||
| 408 | 25087786 |
US |
2 | |
Product use issue, Device defective, |
||||
MEDROXYPROGESTERONE ACETATE, |
||||
| 409 | 25087793 |
US |
||
Incorrect dose administered, Product use issue, Device malfunction, |
||||
MEDROXYPROGESTERONE ACETATE, |
||||
| 410 | 25087800 |
US |
||
Product use issue, Product complaint, |
||||
MEDROXYPROGESTERONE ACETATE, |
||||
| 411 | 25087841 |
US |
2 | |
Product use issue, |
||||
MEDROXYPROGESTERONE ACETATE, |
||||
| 412 | 25087842 |
US |
2 | |
Product use issue, Device malfunction, |
||||
| 413 | 25087844 |
US |
||
Product quality issue, Product use issue, |
||||
MEDROXYPROGESTERONE ACETATE, |
||||
| 414 | 25087846 |
US |
||
Product use issue, Product quality issue, |
||||
MEDROXYPROGESTERONE ACETATE, |
||||
| 415 | 25087858 |
US |
||
Product use issue, Product dispensing issue, Product delivery mechanism issue, |
||||
MEDROXYPROGESTERONE ACETATE, |
||||
| 416 | 25087963 |
US |
67 | 2 |
Off label use, Product use issue, |
||||
TUCATINIB, CAPECITABINE, |
||||
| 417 | 25088111 |
US |
2 | |
Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 418 | 25088315 |
US |
||
Device occlusion, Off label use, Product use issue, |
||||
VIBEGRON, |
||||
| 419 | 25088400 |
US |
81 | 2 |
Wound, Off label use, Product use issue, |
||||
ABATACEPT, |
||||
| 420 | 25088415 |
US |
||
Therapy interrupted, Product use issue, |
||||
RELUGOLIX, AMMONIUM LACTATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, ENALAPRIL MALEATE, |
||||
| 421 | 25088462 |
US |
60 | |
Product use issue, |
||||
ABATACEPT, |
||||
| 422 | 25088740 |
US |
2 | |
Product adhesion issue, Product use issue, |
||||
ESTRADIOL, |
||||
| 423 | 25088910 |
US |
1 | |
Pruritus, Product use issue, |
||||
PEMBROLIZUMAB, LENVATINIB, |
||||
| 424 | 25088951 |
US |
1 | |
Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 425 | 25088974 |
US |
57 | 1 |
Gastric haemorrhage, Product use issue, |
||||
| 426 | 25088978 |
US |
69 | 2 |
Feeling abnormal, Oral mucosal blistering, Chills, Dyskinesia, Product use issue, Incorrect dose administered, |
||||
DEUTETRABENAZINE, |
||||
| 427 | 25089180 |
US |
74 | 2 |
Cerebrovascular accident, Wheelchair user, Cardiac disorder, Amnesia, Product use issue, |
||||
RIFAXIMIN, |
||||
| 428 | 25090264 |
US |
63 | 2 |
Neuropathy peripheral, Diarrhoea, Pain in extremity, Dysphonia, Fatigue, Product use issue, |
||||
REGORAFENIB, |
||||
| 429 | 25090478 |
US |
2 | |
Diarrhoea, Off label use, Product use issue, |
||||
PALBOCICLIB, INAVOLISIB, FULVESTRANT, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 430 | 25090497 |
US |
58 | 2 |
Constipation, Blood calcium increased, Off label use, Product use issue, |
||||
TUCATINIB, TUCATINIB, TUCATINIB, TRASTUZUMAB, |
||||
| 431 | 25090690 |
US |
||
Knee arthroplasty, Product use issue, |
||||
| 432 | 25090707 |
US |
||
Renal disorder, Product use issue, |
||||
ESOMEPRAZOLE MAGNESIUM, |
||||
| 433 | 25091019 |
CA |
77 | 2 |
Infusion site erythema, Infusion site discomfort, Arthritis, Infusion related reaction, Eye swelling, Infusion site swelling, Weight increased, Heart rate increased, Thyroid hormones decreased, Injection site erythema, Peripheral swelling, Joint swelling, Swelling face, Pruritus, Burning sensation, Diarrhoea, Dizziness, Blood pressure increased, Erythema, Fatigue, Headache, Product preparation issue, Product use issue, |
||||
BENRALIZUMAB, RABEPRAZOLE, LEVOTHYROXINE SODIUM, MONTELUKAST SODIUM, ALBUTEROL SULFATE, ALBUTEROL, IPRATROPIUM BROMIDE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, CICLESONIDE, |
||||
| 434 | 25091118 |
US |
2 | |
Blood pressure decreased, Peripheral swelling, Stoma site haemorrhage, Blood potassium decreased, Weight decreased, Blood iron decreased, Diarrhoea, Blood creatinine increased, Product use issue, Insurance issue, Nausea, |
||||
TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, |
||||
| 435 | 25091144 |
BR |
27 | 2 |
Suicide attempt, Discomfort, Somnolence, Product use issue, Malaise, |
||||
IPRATROPIUM BROMIDE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, ALPRAZOLAM, AZITHROMYCIN DIHYDRATE, |
||||
| 436 | 25091953 |
FR |
18 | 1 |
Hypogammaglobulinaemia, Off label use, Blood immunoglobulin G decreased, Product use issue, Product use in unapproved indication, |
||||
DARATUMUMAB, OBINUTUZUMAB, METHYLPREDNISOLONE, PREDNISONE, PREDNISONE, PREDNISONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
| 437 | 25092058 |
US |
31 | 2 |
Abortion induced, Pregnancy with implant contraceptive, Unintended pregnancy, Product use issue, |
||||
ETONOGESTREL, |
||||
| 438 | 25094750 |
|||
Product dispensing error, Incorrect dose administered, Product dispensing error, Product use issue, |
||||
LIRAGLUTIDE, INSULIN GLARGINE, INSULIN ASPART, LIRAGLUTIDE, METOPROLOL TARTRATE, METOPROLOL, TOPIRAMATE, PREDNISONE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, ALPRAZOLAM, ZOLPIDEM TARTRATE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, RIMEGEPANT SULFATE, ALBUTEROL SULFATE, ALBUTEROL, TIZANIDINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, ERGOCALCIFEROL, FISH OIL, |
||||
| 439 | 25081745 |
CA |
43 | 2 |
Pulmonary fibrosis, Osteoarthritis, Osteoporosis, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Prescribed overdose, Prescribed underdose, Product use in unapproved indication, Product use issue, Pruritus, Psoriasis, Psoriatic arthropathy, Pyrexia, Pneumonia, Oedema peripheral, Intentional product use issue, Off label use, Rash, Red blood cell sedimentation rate increased, Retinitis, Rheumatic fever, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, OXYCODONE, OXYCODONE, OXYCODONE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, ERENUMAB-AOOE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SECUKINUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, |
||||
| 440 | 25081815 |
US |
55 | 2 |
Endodontic procedure, Neck mass, Product use issue, Inappropriate schedule of product administration, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, |
||||
| 441 | 25081991 |
US |
1 | |
Death, Diarrhoea, Balance disorder, Dehydration, Malaise, Prescribed overdose, Insurance issue, Product availability issue, Product use issue, Incorrect dose administered, Electrolyte imbalance, |
||||
TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, |
||||
| 442 | 25082241 |
CA |
50 | 2 |
Pericarditis, Osteoarthritis, Sciatica, Treatment failure, Off label use, Urticaria, Musculoskeletal stiffness, Maternal exposure during pregnancy, Product use issue, Lower limb fracture, Lung disorder, Pemphigus, Rheumatoid factor positive, Oedema, Night sweats, Swollen joint count, Therapy non-responder, Type 2 diabetes mellitus, Rheumatoid arthritis, Nasopharyngitis, Swelling, Obesity, Malaise, Vomiting, Weight increased, Rheumatic fever, Stomatitis, Systemic lupus erythematosus, Paraesthesia, Wheezing, Peripheral swelling, Sleep disorder due to general medical condition, hypersomnia type, Muscle injury, Musculoskeletal pain, Prescribed overdose, Psoriatic arthropathy, Sinusitis, Muscle spasms, Mobility decreased, Pruritus, Pyrexia, Lower respiratory tract infection, Swollen joint count increased, Wound, Therapeutic product effect decreased, Rash, Peripheral venous disease, Pain, Pregnancy, Road traffic accident, Product use in unapproved indication, Tender joint count, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, |
||||
| 443 | 25082429 |
US |
81 | 1 |
Neoplasm malignant, Product use issue, Insurance issue, Needle issue, |
||||
TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, |
||||
| 444 | 25082468 |
US |
68 | 1 |
Pain, Product use issue, |
||||
ABATACEPT, |
||||
| 445 | 25082588 |
FR |
42 | 1 |
Erectile dysfunction, Product use issue, |
||||
SEMAGLUTIDE, |
||||
| 446 | 25082636 |
US |
34 | 1 |
Product dose omission issue, Product use issue, |
||||
DOLUTEGRAVIR SODIUM AND LAMIVUDINE, |
||||
| 447 | 25083205 |
ES |
5 | 2 |
Retinal detachment, Glaucoma, Deafness, Product use issue, Product use issue, Product use in unapproved indication, |
||||
MELPHALAN, MELPHALAN, TOPOTECAN, TOPOTECAN, TOPOTECAN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, ETOPOSIDE, ETOPOSIDE, ETOPOSIDE, THIOTEPA, NAXITAMAB, SARGRAMOSTIM, |
||||
| 448 | 25083218 |
US |
72 | 2 |
Drug ineffective, Product use issue, Product availability issue, |
||||
ESTRADIOL, ESTRADIOL, |
||||
| 449 | 25083511 |
US |
77 | |
Product use issue, Adverse event, |
||||
LENALIDOMIDE, |
||||
| 450 | 25083520 |
US |
63 | 1 |
Hallucination, Product use issue, Product distribution issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 451 | 25083991 |
US |
||
Drug dependence, Inappropriate schedule of product administration, Product use issue, |
||||
| 452 | 25084056 |
CA |
2 | |
Off label use, Intentional product misuse, Exposure during pregnancy, Overdose, Pain, Product use issue, Infusion related reaction, Prescribed overdose, |
||||
MONTELUKAST SODIUM, MONTELUKAST, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PROGESTERONE, QUETIAPINE FUMARATE, QUETIAPINE, GABAPENTIN, TOCILIZUMAB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, ALBUTEROL SULFATE, VITAMIN C, BUPROPION HYDROCHLORIDE, ABACAVIR SULFATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL, BUPROPION HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CLONIDINE, CYCLOBENZAPRINE, MEPERIDINE HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, FLUTICASONE PROPIONATE, TRIPROLIDINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, FLUTICASONE PROPIONATE, FLUCONAZOLE, FUROSEMIDE, ADALIMUMAB, HYDROMORPHONE HYDROCHLORIDE, KETOPROFEN, METHYLPREDNISOLONE ACETATE, MORPHINE, MOXIFLOXACIN HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, ABATACEPT, PANTOPRAZOLE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, RANITIDINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, INFLIXIMAB, TEMAZEPAM, RITUXIMAB, ALBUTEROL SULFATE, ALBUTEROL, SENNA LEAF, SENNOSIDES, STANDARDIZED SENNA CONCENTRATE, TEMAZEPAM, TOCILIZUMAB, TOCILIZUMAB, FLUTICASONE PROPIONATE, TRIPROLIDINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, |
||||
| 453 | 25084067 |
CA |
50 | 2 |
Muscle spasms, Musculoskeletal stiffness, Osteoarthritis, Peripheral venous disease, Product use in unapproved indication, Nasopharyngitis, Off label use, Paraesthesia, Prescribed overdose, Tender joint count, Treatment failure, Malaise, Maternal exposure during pregnancy, Musculoskeletal pain, Peripheral swelling, Pruritus, Rash, Rheumatoid factor positive, Swollen joint count increased, Night sweats, Pregnancy, Product use issue, Pyrexia, Road traffic accident, Therapy non-responder, Urticaria, Muscle injury, Oedema, Rheumatoid arthritis, Sinusitis, Sleep disorder due to general medical condition, hypersomnia type, Swelling, Type 2 diabetes mellitus, Weight increased, Lung disorder, Pain, Psoriatic arthropathy, Rheumatic fever, Vomiting, Lower limb fracture, Mobility decreased, Obesity, Sciatica, Stomatitis, Swollen joint count, Wheezing, Lower respiratory tract infection, Pemphigus, Pericarditis, Systemic lupus erythematosus, Therapeutic product effect decreased, Wound, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, |
||||
| 454 | 25084080 |
CA |
2 | |
Hyperhidrosis, Hypersensitivity, Infusion related reaction, Product use issue, Food allergy, Hypertension, Headache, Joint swelling, Pain, Exposure during pregnancy, Off label use, Overdose, Prescribed overdose, Hepatic enzyme increased, Immunodeficiency, Intentional product misuse, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, ABACAVIR SULFATE, TOCILIZUMAB, ALBUTEROL SULFATE, ALBUTEROL, BUPROPION HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CLONIDINE, PROGESTERONE, CYCLOBENZAPRINE, PANTOPRAZOLE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
| 455 | 25084414 |
CA |
||
Diffuse large B-cell lymphoma recurrent, Product use issue, |
||||
RITUXIMAB, RITUXIMAB, METHOTREXATE, METHOTREXATE SODIUM, CISPLATIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 456 | 25084415 |
CN |
56 | 1 |
Septic shock, Immune-mediated lung disease, Respiratory failure, Respiratory distress, Immune-mediated lung disease, Product use issue, |
||||
PEMBROLIZUMAB, |
||||
| 457 | 25084539 |
TW |
||
Cerebrovascular accident, Off label use, Product use issue, |
||||
ENCORAFENIB, ENCORAFENIB, CETUXIMAB, CETUXIMAB, |
||||
| 458 | 25084602 |
US |
||
Product use issue, Incorrect dose administered, Product packaging issue, |
||||
ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, |
||||
| 459 | 25084845 |
CN |
51 | 1 |
Coma, Blood sodium increased, Product use issue, |
||||
TOLVAPTAN, FUROSEMIDE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 460 | 25084989 |
US |
1 | |
Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 461 | 25084991 |
US |
83 | 1 |
Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 462 | 25084994 |
US |
1 | |
Loss of consciousness, Cardioversion, Physical assault, Fall, Aggression, Therapy interrupted, Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 463 | 25085053 |
NL |
16 | 2 |
Arthralgia, Wrong product administered, Overdose, Product use issue, |
||||
GADOTERATE MEGLUMINE, |
||||
| 464 | 25085059 |
US |
2 | |
Stress, Product dose omission issue, Muscle twitching, Product use issue, |
||||
DEUTETRABENAZINE, |
||||
| 465 | 25085117 |
JP |
||
Colitis ischaemic, Product use issue, |
||||
SENNOSIDES A AND B, |
||||
| 466 | 25085219 |
US |
||
Disorientation, Product use issue, |
||||
CARBAMAZEPINE, |
||||
| 467 | 25085276 |
US |
2 | |
Therapy interrupted, Product use issue, Product distribution issue, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, |
||||
| 468 | 25085401 |
US |
2 | |
Therapy interrupted, Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 469 | 25085427 |
US |
1 | |
Product use issue, |
||||
MITAPIVAT, |
||||
| 470 | 25085522 |
CA |
||
Exposure during pregnancy, Product use issue, Infusion related reaction, Intentional product misuse, Off label use, Overdose, Pain, Prescribed overdose, |
||||
CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ABACAVIR SULFATE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, BUPROPION HYDROCHLORIDE, BUPROPION, BUPROPION HYDROCHLORIDE, BUPROPION, CLONIDINE, CYCLOBENZAPRINE, CYCLOBENZAPRINE, MEPERIDINE HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, FLUCONAZOLE, GABAPENTIN, ADALIMUMAB, ADALIMUMAB, HYDROMORPHONE HYDROCHLORIDE, KETOPROFEN, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, MONTELUKAST SODIUM, MONTELUKAST, MONTELUKAST SODIUM, MONTELUKAST, MORPHINE, MORPHINE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ABATACEPT, ABATACEPT, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PROGESTERONE, PROGESTERONE, QUETIAPINE FUMARATE, QUETIAPINE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, INFLIXIMAB, TEMAZEPAM, RITUXIMAB, RITUXIMAB, ALBUTEROL SULFATE, ALBUTEROL, SENNA LEAF, SENNA LEAF, SENNOSIDES, STANDARDIZED SENNA CONCENTRATE, STANDARDIZED SENNA CONCENTRATE, TEMAZEPAM, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, ALBUTEROL SULFATE, VITAMIN C, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, |
||||
| 471 | 25085710 |
CA |
51 | 2 |
Product use issue, Abdominal discomfort, Drug intolerance, Therapy non-responder, Product substitution issue, |
||||
DONEPEZIL HYDROCHLORIDE, VITAMIN C, |
||||
| 472 | 25085867 |
US |
||
Laboratory test abnormal, Myalgia, Muscle spasms, Pain, Bone pain, Constipation, Back pain, Product availability issue, Product use issue, |
||||
ELACESTRANT, ELACESTRANT, |
||||
| 473 | 25085909 |
US |
||
Colitis, Melaena, Feeding disorder, Gastrointestinal disorder, Anal incontinence, Diarrhoea, Hyperhidrosis, Abdominal pain upper, Flatulence, Vomiting, Product use issue, |
||||
ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, |
||||
| 474 | 25085960 |
US |
2 | |
Cough, Incorrect dose administered by device, Product use issue, |
||||
CICLESONIDE, |
||||
| 475 | 25086236 |
US |
17 | 1 |
Product use issue, |
||||
ISOTRETINOIN, |
||||
| 476 | 25086322 |
US |
73 | 1 |
Product use issue, |
||||
LENALIDOMIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE, APIXABAN, ACYCLOVIR, GABAPENTIN, ROSUVASTATIN CALCIUM, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, PREDNISONE, |
||||
| 477 | 25086655 |
DE |
7 | 2 |
Drug hypersensitivity, Drug ineffective, Hypersensitivity, Condition aggravated, Product use issue, |
||||
AMPHOTERICIN B, AMPHOTERICIN B, AMPHOTERICIN B, VORICONAZOLE, VORICONAZOLE, AMPHOTERICIN B, AMPHOTERICIN B, AMPHOTERICIN B, CYTARABINE, ETOPOSIDE, MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE, |
||||
| 478 | 25086661 |
KR |
||
Pulmonary embolism, Deep vein thrombosis, Hypertension, Dyspnoea, Dyspnoea, Oedema peripheral, Product use issue, |
||||
TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, LEVOTHYROXINE SODIUM, TRAMADOL HYDROCHLORIDE, AMLODIPINE BESYLATE, URSODIOL, URSOSIOL, URSODIOL, URSOSIOL, |
||||
| 479 | 25089718 |
|||
Product use issue, Insurance issue, Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 480 | 25081405 |
US |
61 | 2 |
Wrong technique in device usage process, Product use issue, Product complaint, |
||||
FLUTICASONE FUROATE, |
||||
| 481 | 25081548 |
US |
15 | |
Product use issue, |
||||
ISOTRETINOIN, |
||||
| 482 | 25081567 |
US |
79 | 2 |
Product use issue, |
||||
APIXABAN, |
||||
| 483 | 25081638 |
US |
66 | 2 |
Pneumonia, Product use issue, Off label use, |
||||
| 484 | 25084215 |
1 | ||
Asthma, Influenza, Therapy cessation, Product use issue, |
||||
MEPOLIZUMAB, |
||||
| 485 | 25080383 |
US |
6 | 1 |
Product use issue, |
||||
OMEPRAZOLE AND SODIUM BICARBONATE, |
||||
| 486 | 25080384 |
US |
4 | 2 |
Product use issue, Product storage error, |
||||
OMEPRAZOLE AND SODIUM BICARBONATE, |
||||
| 487 | 25080386 |
US |
||
Product use issue, Product temperature excursion issue, |
||||
OMEPRAZOLE AND SODIUM BICARBONATE, |
||||
| 488 | 25080389 |
US |
||
Product use issue, Product storage error, |
||||
OMEPRAZOLE AND SODIUM BICARBONATE, |
||||
| 489 | 25080390 |
US |
13 | 2 |
Product prescribing issue, Product use issue, Product storage error, |
||||
OMEPRAZOLE AND SODIUM BICARBONATE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 490 | 25080600 |
US |
2 | |
Feeling abnormal, Vision blurred, Hot flush, Toothache, Tooth fracture, Tooth disorder, Chest discomfort, Paraesthesia, Muscle spasms, Chest pain, Costochondritis, Gait disturbance, Abdominal discomfort, Vomiting, Loss of personal independence in daily activities, Product use issue, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 491 | 25081156 |
US |
70 | 2 |
Product use issue, |
||||
TESTOSTERONE, TESTOSTERONE, TESTOSTERONE,, |
||||
| 492 | 25076922 |
DE |
75 | 2 |
General physical health deterioration, Hyperkinesia, Product use issue, |
||||
MORPHINE, |
||||
| 493 | 25077005 |
CA |
43 | 2 |
Peripheral swelling, Pneumonia, Pruritus, Psoriatic arthropathy, Pulmonary fibrosis, Pyrexia, Rash, Rheumatic fever, Osteoarthritis, Pain, Pericarditis, Pemphigus, Psoriasis, Oedema peripheral, Red blood cell sedimentation rate increased, Retinitis, Osteoporosis, Pain in extremity, Prescribed overdose, Prescribed underdose, Product use in unapproved indication, Intentional product use issue, Off label use, Product use issue, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ERENUMAB-AOOE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, OXYCODONE, OXYCODONE, OXYCODONE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, |
||||
| 494 | 25077103 |
US |
1 | |
Hallucination, Depressed mood, Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 495 | 25077167 |
GB |
68 | 1 |
Pneumonitis, Progressive massive fibrosis, Interstitial lung disease, Infection, Product use issue, |
||||
NINTEDANIB, |
||||
| 496 | 25077259 |
JP |
8 | |
Product use issue, |
||||
SOLIFENACIN SUCCINATE, |
||||
| 497 | 25077355 |
GB |
55 | 2 |
Disease progression, Lung consolidation, Interstitial lung disease, Pneumonitis, Respiratory failure, Lower respiratory tract infection, Influenza, Pulmonary embolism, Product use issue, Cytomegalovirus infection, |
||||
NINTEDANIB, |
||||
| 498 | 25077377 |
US |
57 | 2 |
Product use issue, Thrombosis, |
||||
APIXABAN, |
||||
| 499 | 25077489 |
US |
84 | 1 |
Dyspepsia, Flatulence, Jaw disorder, Diarrhoea, Muscle strain, Product use in unapproved indication, Mastication disorder, Product use issue, Depression, Walking aid user, Dysphagia, Device related infection, Loss of personal independence in daily activities, |
||||
DEUTETRABENAZINE, DEUTETRABENAZINE, ALLOPURINOL, FUROSEMIDE, LATANOPROST, LINACLOTIDE, MONTELUKAST, CYCLOSPORINE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ALBUTEROL SULFATE, CLONAZEPAM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, FINASTERIDE, GABAPENTIN, POTASSIUM CHLORATE, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, |
||||
| 500 | 25077505 |
US |
76 | 2 |
Arthropathy, Atrial fibrillation, Product use issue, |
||||
APIXABAN, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28